EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Incidence and radiographic progression of rheumatoid arthritis in anti-citrullinated protein antibody-positive individuals: A 6-year population-based cohort study

Kenta Makabe, Takumi Matsumoto iD, Akihiro Uchio, Hiroyasu Mizuhara, Ryutaro Takeda, Toshiko Iidaka, Taro Kasai, Yasunori Omata, Sakae Tanaka iD, Noriko Yoshimura

Modern Rheumatology · 04.11.2026 · 36 (6) · 918-926

DOI: 10.1093/mr/roag051 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Modern Rheumatology, online erschienen am 29.06.2026. Verfasst von Kenta Makabe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Anti-Citrullinated Protein Antibodies, Autoantibodies. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: JCR Grant for Promoting Research for Early RA, Ministry of Health, Labour and Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Anti-citrullinated protein antibodies (ACPA) predict rheumatoid arthritis (RA) and radiographic joint destruction. However, data on long-term outcomes in ACPA-positive individuals without RA are limited. This study aimed to investigate the 6-year cumulative incidence of RA and radiographic progression among ACPA-positive individuals without RA at baseline in a population-based cohort.

Method

A total of 1541 participants without RA at baseline were enrolled from the population-based cohort, of whom 28 tested positive for ACPA. Incident cases of RA were identified based on participants’ self-reported physician diagnosis and medication history over a 6-year follow-up period. Radiographic progression in the hands was assessed using the van der Heijde modified Sharp score.

Results

Five participants developed RA within the first 3 years, including three who were ACPA-positive at baseline (all with high ACPA titres). After 3 years, additional RA cases were identified only among participants who were ACPA-negative at baseline, whereas no further cases occurred among those who were ACPA-positive at baseline. The positive predictive value of ACPA for RA within 3 years was 15.0%, rising to 30.0% among those with high ACPA titres. When it was combined with the rheumatoid factor or matrix metalloproteinase-3, the positive predictive value further increased. Radiographic progression occurred in all participants with high-titre ACPA who developed RA (n = 3) and in one ACPA-positive individual without RA, but not in ACPA-negative individuals who developed RA.

Conclusions

ACPA positivity, particularly at high titres, may be associated with an increased risk of incident RA and with radiographic bone destruction, even in the absence of clinical symptoms or an RA diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidAnti-Citrullinated Protein AntibodiesAutoantibodiesHumansDisease ProgressionFemaleMiddle AgedRadiographyMaleIncidenceAdultCohort StudiesAged

Stichwörter der Autor:innen

Anti-citrullinated protein antibodiesbiomarkerpopulation-based cohort studyradiographic progressionrheumatoid arthritis

Substanzen

Anti-Citrullinated Protein AntibodiesAutoantibodies

Autor:innen und Institutionen

  • Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Orthopaedics, Jichi Medical University, Tochigi, Japan.
  • Department of Preventive Medicine for Locomotive Organ Disorders, 22nd Century Medical and Research Center, The University of Tokyo, Tokyo, Japan.

ORCID-Profile: Takumi Matsumoto, Sakae Tanaka

Förderung

  • JCR Grant for Promoting Research for Early RA
  • Ministry of Health, Labour and Welfare

Zitieren

APA

Makabe, K., Matsumoto, T., Uchio, A., Mizuhara, H., Takeda, R., Iidaka, T., Kasai, T., Omata, Y., Tanaka, S., & Yoshimura, N. (2026). Incidence and radiographic progression of rheumatoid arthritis in anti-citrullinated protein antibody-positive individuals: A 6-year population-based cohort study. Modern Rheumatology, 36(6), 918-926. https://doi.org/10.1093/mr/roag051

Vancouver

Makabe K, Matsumoto T, Uchio A, Mizuhara H, Takeda R, Iidaka T, et al. Incidence and radiographic progression of rheumatoid arthritis in anti-citrullinated protein antibody-positive individuals: A 6-year population-based cohort study. Modern Rheumatology. 2026;36(6):918-926. doi:10.1093/mr/roag051

BibTeX
@article{Makabe2026,
  author = {Makabe, Kenta and Matsumoto, Takumi and Uchio, Akihiro and Mizuhara, Hiroyasu and Takeda, Ryutaro and Iidaka, Toshiko and Kasai, Taro and Omata, Yasunori and Tanaka, Sakae and Yoshimura, Noriko},
  title = {Incidence and radiographic progression of rheumatoid arthritis in anti-citrullinated protein antibody-positive individuals: A 6-year population-based cohort study},
  journal = {Modern Rheumatology},
  year = {2026},
  volume = {36},
  number = {6},
  pages = {918--926},
  doi = {10.1093/mr/roag051}
}
Kostenlos starten →